Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Characterization of M1 and M2 polarization phenotypes in peritoneal macrophages after treatment with graphene oxide nanosheets.

Feito MJ, Diez-Orejas R, Cicuéndez M, Casarrubios L, Rojo JM, Portolés MT.

Colloids Surf B Biointerfaces. 2019 Apr 1;176:96-105. doi: 10.1016/j.colsurfb.2018.12.063. Epub 2018 Dec 22.

PMID:
30594708
2.

Response of macrophages and neural cells in contact with reduced graphene oxide microfibers.

Serrano MC, Feito MJ, González-Mayorga A, Diez-Orejas R, Matesanz MC, Portolés MT.

Biomater Sci. 2018 Nov 1;6(11):2987-2997. doi: 10.1039/c8bm00902c. Epub 2018 Sep 26.

PMID:
30255874
3.

Graphene oxide nanosheets increase Candida albicans killing by pro-inflammatory and reparative peritoneal macrophages.

Diez-Orejas R, Feito MJ, Cicuéndez M, Casarrubios L, Rojo JM, Portolés MT.

Colloids Surf B Biointerfaces. 2018 Nov 1;171:250-259. doi: 10.1016/j.colsurfb.2018.07.027. Epub 2018 Jul 21.

PMID:
30036792
4.

Educating in antimicrobial resistance awareness: adaptation of the Small World Initiative program to service-learning.

Valderrama MJ, González-Zorn B, de Pablo PC, Díez-Orejas R, Fernández-Acero T, Gil-Serna J, de Juan L, Martín H, Molina M, Navarro-García F, Patiño B, Pla J, Prieto D, Rodríguez C, Román E, Sanz-Santamaría AB, de Silóniz MI, Suárez M, Vázquez C, Cid VJ.

FEMS Microbiol Lett. 2018 Sep 1;365(17). doi: 10.1093/femsle/fny161.

PMID:
29982335
5.

TUP1-mediated filamentation in Candida albicans leads to inability to colonize the mouse gut.

Román E, Huertas B, Prieto D, Díez-Orejas R, Pla J.

Future Microbiol. 2018 Jun 1;13:857-867. doi: 10.2217/fmb-2018-0012. Epub 2018 Jun 7.

PMID:
29877100
6.

Differential effects of graphene oxide nanosheets on Candida albicans phagocytosis by murine peritoneal macrophages.

Diez-Orejas R, Feito MJ, Cicuéndez M, Rojo JM, Portolés MT.

J Colloid Interface Sci. 2018 Feb 15;512:665-673. doi: 10.1016/j.jcis.2017.10.104. Epub 2017 Oct 28.

PMID:
29107917
7.

Serum Antibody Profile during Colonization of the Mouse Gut by Candida albicans: Relevance for Protection during Systemic Infection.

Huertas B, Prieto D, Pitarch A, Gil C, Pla J, Díez-Orejas R.

J Proteome Res. 2017 Jan 6;16(1):335-345. doi: 10.1021/acs.jproteome.6b00383. Epub 2016 Sep 30.

PMID:
27539120
8.

Estradiol impairs the Th17 immune response against Candida albicans.

Relloso M, Aragoneses-Fenoll L, Lasarte S, Bourgeois C, Romera G, Kuchler K, Corbí AL, Muñoz-Fernández MA, Nombela C, Rodríguez-Fernández JL, Diez-Orejas R.

J Leukoc Biol. 2012 Jan;91(1):159-65. doi: 10.1189/jlb.1110645. Epub 2011 Sep 30.

PMID:
21965175
9.

The Candida albicans cell wall protein Rhd3/Pga29 is abundant in the yeast form and contributes to virulence.

de Boer AD, de Groot PW, Weindl G, Schaller M, Riedel D, Diez-Orejas R, Klis FM, de Koster CG, Dekker HL, Gross U, Bader O, Weig M.

Yeast. 2010 Aug;27(8):611-24. doi: 10.1002/yea.1790.

10.

Candida albicans actively modulates intracellular membrane trafficking in mouse macrophage phagosomes.

Fernández-Arenas E, Bleck CK, Nombela C, Gil C, Griffiths G, Diez-Orejas R.

Cell Microbiol. 2009 Apr;11(4):560-89. doi: 10.1111/j.1462-5822.2008.01274.x. Epub 2008 Dec 24.

PMID:
19134116
11.

Candida albicans-macrophage interactions: genomic and proteomic insights.

Diez-Orejas R, Fernández-Arenas E.

Future Microbiol. 2008 Dec;3(6):661-81. doi: 10.2217/17460913.3.6.661. Review.

PMID:
19072183
12.

Immunoproteomic analysis of the protective response obtained from vaccination with Candida albicans ecm33 cell wall mutant in mice.

Martínez-López R, Nombela C, Diez-Orejas R, Monteoliva L, Gil C.

Proteomics. 2008 Jul;8(13):2651-64. doi: 10.1002/pmic.200701056.

PMID:
18546157
13.

Combined inactivation of the Candida albicans GPR1 and TPS2 genes results in avirulence in a mouse model for systemic infection.

Maidan MM, De Rop L, Relloso M, Diez-Orejas R, Thevelein JM, Van Dijck P.

Infect Immun. 2008 Apr;76(4):1686-94. doi: 10.1128/IAI.01497-07. Epub 2008 Feb 11.

14.

Integrated proteomics and genomics strategies bring new insight into Candida albicans response upon macrophage interaction.

Fernández-Arenas E, Cabezón V, Bermejo C, Arroyo J, Nombela C, Diez-Orejas R, Gil C.

Mol Cell Proteomics. 2007 Mar;6(3):460-78. Epub 2006 Dec 12.

15.

The importance of the phagocytes' innate response in resolution of the infection induced by a low virulent Candida albicans mutant.

Molero G, Guillén MV, Martínez-Solano L, Gil C, Pla J, Nombela C, Sánchez-Pérez M, Diez-Orejas R.

Scand J Immunol. 2005 Sep;62(3):224-33.

16.

The GPI-anchored protein CaEcm33p is required for cell wall integrity, morphogenesis and virulence in Candida albicans.

Martinez-Lopez R, Monteoliva L, Diez-Orejas R, Nombela C, Gil C.

Microbiology. 2004 Oct;150(Pt 10):3341-54.

PMID:
15470113
17.

Low virulent strains of Candida albicans: unravelling the antigens for a future vaccine.

Fernández-Arenas E, Molero G, Nombela C, Diez-Orejas R, Gil C.

Proteomics. 2004 Oct;4(10):3007-20.

PMID:
15378749
18.

Contribution of the antibodies response induced by a low virulent Candida albicans strain in protection against systemic candidiasis.

Fernández-Arenas E, Molero G, Nombela C, Diez-Orejas R, Gil C.

Proteomics. 2004 Apr;4(4):1204-15. Erratum in: Proteomics. 2004 Aug;4(8):2513. Dosage error in article text.

PMID:
15049000
19.

Two-dimensional reference map of Candida albicans hyphal forms.

Hernández R, Nombela C, Diez-Orejas R, Gil C.

Proteomics. 2004 Feb;4(2):374-82.

PMID:
14760707
20.

Analysis of the serologic response to systemic Candida albicans infection in a murine model.

Pitarch A, Díez-Orejas R, Molero G, Pardo M, Sánchez M, Gil C, Nombela C.

Proteomics. 2001 Apr;1(4):550-9.

PMID:
11681208
21.

Two different NO-dependent mechanisms account for the low virulence of a non-mycelial morphological mutant of Candida albicans.

Diez-Orejas R, Molero G, Moro MA, Gil C, Nombela C, Sánchez-Pérez M.

Med Microbiol Immunol. 2001 Apr;189(3):153-60.

PMID:
11388613
22.

Candida albicans: genetics, dimorphism and pathogenicity.

Molero G, Díez-Orejas R, Navarro-García F, Monteoliva L, Pla J, Gil C, Sánchez-Pérez M, Nombela C.

Int Microbiol. 1998 Jun;1(2):95-106. Review.

PMID:
10943347
23.

Low virulence of a morphological Candida albicans mutant.

Diez-Orejas R, Molero G, Ríos-Serrano I, Vázquez A, Gil C, Nombela C, Sánchez-Pérez M.

FEMS Microbiol Lett. 1999 Jul 15;176(2):311-9.

24.

Role of the mitogen-activated protein kinase Hog1p in morphogenesis and virulence of Candida albicans.

Alonso-Monge R, Navarro-García F, Molero G, Diez-Orejas R, Gustin M, Pla J, Sánchez M, Nombela C.

J Bacteriol. 1999 May;181(10):3058-68.

25.

Phenotypic characterization of a Candida albicans strain deficient in its major exoglucanase.

González MM, Díez-Orejas R, Molero G, Alvarez AM, Pla J, Nombela C, Sánchez-Pérez M.

Microbiology. 1997 Sep;143 ( Pt 9):3023-32.

PMID:
9308184
26.

CD4 dependence of activation threshold and TCR signalling in mouse T lymphocytes.

Feito MJ, Ballester S, Díez-Orejas R, Ojeda G, Criado G, Portolés P, Rojo JM.

Scand J Immunol. 1997 Feb;45(2):166-74.

27.

Reduced virulence of Candida albicans MKC1 mutants: a role for mitogen-activated protein kinase in pathogenesis.

Diez-Orejas R, Molero G, Navarro-García F, Pla J, Nombela C, Sanchez-Pérez M.

Infect Immun. 1997 Feb;65(2):833-7.

28.

A hyperreactive variant of a CD4+ T cell line is activated by syngeneic antigen presenting cells in the absence of antigen.

Ojeda G, Ronda M, Ballester S, Díez-Orejas R, Feito MJ, García-Albert L, Rojo JM, Portolés P.

Cell Immunol. 1995 Sep;164(2):265-78.

PMID:
7656334
29.

Molecular analysis of an HLA-DP mutant cell line selected for its resistance to killing by HLA-DPw2-specific T-cell clones.

Arroyo J, Díez-Orejas R, Alvarez AM, Shaw S, Sánchez-Pérez M.

Immunogenetics. 1994;39(1):40-7.

PMID:
8225437
30.

Genetic and immunochemical evidence for CD4-dependent association of p56lck with the alpha beta T-cell receptor (TCR): regulation of TCR-induced activation.

Díez-Orejas R, Ballester S, Feito MJ, Ojeda G, Criado G, Ronda M, Portolés P, Rojo JM.

EMBO J. 1994 Jan 1;13(1):90-9.

31.

Polyerga, a biological response modifier enhancing T-lymphocyte-dependent responses.

de Ojeda G, Diez-Orejas R, Portolés P, Ronda M, Del Pozo ML, Feito MJ, Hartleb M, Rojo JM.

Res Exp Med (Berl). 1994;194(4):261-7.

PMID:
7800935
32.

Supplemental Content

Loading ...
Support Center